Coloplast AS (XTER:CBHD)
€ 123.2 1.15 (0.94%) Market Cap: 27.56 Bil Enterprise Value: 30.48 Bil PE Ratio: 40.61 PB Ratio: 11.45 GF Score: 92/100

Q2 2021 Coloplast A/S Earnings Call Transcript

May 06, 2021 / 01:00PM GMT
Release Date Price: €130.9 (-4.87%)
Operator

Welcome to the Coloplast Q2 Conference Call. (Operator Instructions) Please note, this call is being recorded. I'll now hand the floor to our speakers in your meeting.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Good afternoon, and welcome to our first half 2021 conference call. My name is Kristian Villumsen, CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard and our Investor Relations team. We'll start with a short presentation by Anders and myself, like we usually do, and then we'll open up for questions.

Please turn to Slide #3. After an encouraging start to the year in Q1, we had expected a weaker second quarter due to a large stocking impact in our baseline and the continued negative impact of COVID-19 on our European Chronic Care business. We delivered 2% organic growth, a 33% EBIT margin before special items and a return on invested capital before special items of 42%. Adjusted for the DKK 150 million stocking effect in Q2 of last year, organic growth was around 5% for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot